Education
About Us
Working with TipRanks
Follow Us
Timothy Coughlin Insider Profile
4 Followers
Timothy Coughlin, CFO at Neurocrine, holds 55.50K shares in Travere Therapeutics (Ticker: TVTX), holds 40.00K shares in ADC Therapeutics (Ticker: ADCT), holds 56.00K shares in aTyr Pharma (Ticker: ATYR).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+101.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Timothy Coughlin holds in companies
Most Profitable Insider Trade
The most profitable trade made by Timothy Coughlin
Timothy Coughlin's Trading History
Neurocrine
Feb 08, 2017
CFO
Uninformative Sell
41.54K
$17.03M
aTyr Pharma
Jun 03, 2024
Director
Informative Buy
87.50K
$50.51K
ADC Therapeutics
Jun 05, 2025
Director
Uninformative Buy
―
$167.60K
Travere Therapeutics
Nov 04, 2025
Director
Uninformative Buy
305.04K
$1.52M
Fate Therapeutics
Jun 13, 2022
Director
Uninformative Buy
―
$91.47K
List of latest transactions for each holding click on a transaction to see Timothy Coughlin's performance on stock
You May Also Like
Timothy Coughlin insider profile FAQ
What is the percentage of profitable transactions made by Timothy Coughlin?
The percentage of profitable transactions made by Timothy Coughlin is 100%.
What is the average return per transaction made by Timothy Coughlin?
The average return per transaction made by Timothy Coughlin is 101.70%.
What stocks does Timothy Coughlin hold?
Timothy Coughlin holds: NBIX, ATYR, ADCT, TVTX, FATE stocks.
What was Timothy Coughlin’s latest transaction?
Timothy Coughlin latest transaction was an Uninformative Buy of $305.04K.
What was Timothy Coughlin's most profitable transaction?
Timothy Coughlin’s most profitable transaction was an Informative Buy of ATYR stock on June 3, 2024. The return on the trade was 191.30%.
What is Timothy Coughlin's role in Neurocrine?
Timothy Coughlin's role in Neurocrine is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.